JP2018527886A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018527886A5 JP2018527886A5 JP2017565108A JP2017565108A JP2018527886A5 JP 2018527886 A5 JP2018527886 A5 JP 2018527886A5 JP 2017565108 A JP2017565108 A JP 2017565108A JP 2017565108 A JP2017565108 A JP 2017565108A JP 2018527886 A5 JP2018527886 A5 JP 2018527886A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- prognosis
- metastasis
- characterization
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1510684.2A GB201510684D0 (en) | 2015-06-17 | 2015-06-17 | Gene signatures predictive of metastatic disease |
| GB1510684.2 | 2015-06-17 | ||
| PCT/GB2016/051825 WO2016203262A2 (en) | 2015-06-17 | 2016-06-17 | Gene signatures predictive of metastatic disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018527886A JP2018527886A (ja) | 2018-09-27 |
| JP2018527886A5 true JP2018527886A5 (enExample) | 2019-07-04 |
Family
ID=53784091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017565108A Pending JP2018527886A (ja) | 2015-06-17 | 2016-06-17 | 転移性疾患の予測的遺伝子シグネチャー |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210254166A1 (enExample) |
| EP (1) | EP3310927B1 (enExample) |
| JP (1) | JP2018527886A (enExample) |
| CN (1) | CN108513587A (enExample) |
| CA (1) | CA2989388A1 (enExample) |
| GB (1) | GB201510684D0 (enExample) |
| HK (1) | HK1246367A1 (enExample) |
| WO (1) | WO2016203262A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11341138B2 (en) * | 2017-12-06 | 2022-05-24 | International Business Machines Corporation | Method and system for query performance prediction |
| GB201901439D0 (en) * | 2019-02-01 | 2019-03-27 | Univ London | Method of predicting survival rates for cancer patients |
| GB201903015D0 (en) * | 2019-03-08 | 2019-04-17 | Univ Edinburgh | Macrophage expression in breast cancer |
| GB201903014D0 (en) * | 2019-03-06 | 2019-04-17 | Univ Edinburgh | Macrophage markers in cancer |
| JP7741104B2 (ja) * | 2020-01-21 | 2025-09-17 | ジェニアリス インコーポレイテッド | 分子バイオマーカーデータセット全体にわたる予測シグネチャの堅牢性および転用可能性の評価 |
| CA3174199A1 (en) | 2020-04-09 | 2021-10-14 | Ashraf Hafez | Predicting likelihood and site of metastasis from patient records |
| TW202216996A (zh) | 2020-06-29 | 2022-05-01 | 美商Ionis製藥公司 | 調節ｐｌｐ１之化合物及方法 |
| WO2022086914A1 (en) * | 2020-10-19 | 2022-04-28 | Temple University - Of The Commonwealth System Of Higher Education | Genetic approach to suppress coronaviruses |
| CN117741155A (zh) * | 2023-11-21 | 2024-03-22 | 中国药科大学 | Abcc4蛋白用于制备前列腺癌诊断试剂盒的用途 |
| CN120197220B (zh) * | 2025-05-23 | 2025-08-01 | 华信咨询设计研究院有限公司 | 一种基于数据集中度的数据风险评估方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4437975A (en) | 1977-07-20 | 1984-03-20 | Mobil Oil Corporation | Manufacture of lube base stock oil |
| IE72468B1 (en) | 1987-07-31 | 1997-04-09 | Univ Leland Stanford Junior | Selective amplification of target polynucleotide sequences |
| ZA899593B (en) | 1988-12-16 | 1990-09-26 | Siska Diagnostics Inc | Self-sustained,sequence replication system |
| US6017704A (en) | 1996-06-03 | 2000-01-25 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
| EP1474528A4 (en) * | 2000-10-13 | 2006-06-14 | Protein Design Labs Inc | METHODS OF DIAGNOSIS OF PROSTATE CANCER, COMPOSITIONS AND METHODS OF EXAMINING PROSTATE CANCER MODULATORS |
| WO2004067726A2 (en) | 2003-01-29 | 2004-08-12 | Keck Graduate Institute | Isothermal reactions for the amplification of oligonucleotides |
| WO2004085621A2 (en) * | 2003-03-20 | 2004-10-07 | Dana-Farber Cancer Institute, Inc. | Gene expression in breast cancer |
| US7306910B2 (en) * | 2003-04-24 | 2007-12-11 | Veridex, Llc | Breast cancer prognostics |
| JP2008518610A (ja) | 2004-11-03 | 2008-06-05 | アルマック ダイアグノスティックス リミテッド | トランスクリプトームマイクロアレイ技法およびそれを使用する方法 |
| US20140018249A1 (en) * | 2006-07-26 | 2014-01-16 | Health Discovery Corporation | Biomarkers for screening, predicting, and monitoring benign prostate hyperplasia |
| NZ582941A (en) | 2007-08-13 | 2012-05-25 | Almac Diagnostics Ltd | A 3' -based sequencing approach for microarray manufacture |
| DK2376215T3 (en) * | 2008-12-11 | 2019-01-28 | Univ California | FILTER CONE |
| CA2782620A1 (en) * | 2009-12-01 | 2011-06-09 | Compendia Bioscience, Inc. | Classification of cancers |
| CA2836277A1 (en) * | 2011-05-17 | 2012-11-22 | Takeda Pharmaceutical Company Limited | Pharmaceutical compositions and methods for treating cancer |
| WO2014012176A1 (en) * | 2012-07-20 | 2014-01-23 | Diagnocure Inc. | Methods, kits and compositions for providing a clinical assessment of prostate cancer |
-
2015
- 2015-06-17 GB GBGB1510684.2A patent/GB201510684D0/en not_active Ceased
-
2016
- 2016-06-17 US US15/736,667 patent/US20210254166A1/en not_active Abandoned
- 2016-06-17 JP JP2017565108A patent/JP2018527886A/ja active Pending
- 2016-06-17 EP EP16731299.0A patent/EP3310927B1/en active Active
- 2016-06-17 CN CN201680045157.3A patent/CN108513587A/zh active Pending
- 2016-06-17 HK HK18105968.7A patent/HK1246367A1/zh unknown
- 2016-06-17 WO PCT/GB2016/051825 patent/WO2016203262A2/en not_active Ceased
- 2016-06-17 CA CA2989388A patent/CA2989388A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101562644B1 (ko) | 직장결장암용 예후 예측 | |
| JP2017507320A5 (enExample) | ||
| CN102333887B (zh) | 用于检测gi癌转移的方法 | |
| JP2019516407A5 (enExample) | ||
| JP2019516406A5 (enExample) | ||
| Eissa et al. | Evaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosis | |
| CN104975099A (zh) | Hedgehog抑制剂治疗的生物标志物 | |
| JP2013500001A5 (enExample) | ||
| JP2017214360A (ja) | タキサン療法を用いて乳癌を処置する方法 | |
| ES2963390T3 (es) | Método para predecir la eficacia de la quimioterapia en pacientes con cáncer de mama | |
| Schena et al. | DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients | |
| JP7235508B2 (ja) | Ｐｄ－１免疫チェックポイント阻害剤による治療に対するがんの感受性を予測する方法 | |
| US10036070B2 (en) | Methods and means for molecular classification of colorectal cancers | |
| Zhao et al. | Correlation between the expression levels of miR-1 and PIK3CA in non-small-cell lung cancer and their relationship with clinical characteristics and prognosis | |
| CA2989480C (en) | Kit and method for the diagnosis/prognosis of idiopathic scoliosis | |
| US11434537B2 (en) | Biomarker for prognosis of colorectal cancer | |
| Sippl et al. | The influence of distinct regulatory miRNAs of the p15/p16/RB1/E2F pathway on the clinical progression of glioblastoma multiforme | |
| Pavlič et al. | Analyzing the invasive front of colorectal cancer–By punching tissue block or laser capture microdissection? | |
| JP2010523134A (ja) | Ｅｇｆｒ／ｃｓｆ−１／ｃａｉｘ発現に基づき非小細胞肺癌の化学療法計画および生存余命を決定する方法 | |
| CN118922561A (zh) | 肾癌诊断用尿液miRNA标志物、诊断试剂及试剂盒 | |
| CN102361990A (zh) | 通过监测两种基因的表达的乳腺癌患者的预后 | |
| JP2024170603A (ja) | 免疫チェックポイント阻害療法からの利益を予測する方法 | |
| CN111315897B (zh) | 用于黑素瘤检测的方法 | |
| KR101381894B1 (ko) | 위암의 림프절 전이 진단 마커로서의 혈청 ｍｉＲＮＡ | |
| CN112813167B (zh) | 标志物linc01977及其应用 |